An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
- 4 November 2011
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 26 (5), 951-958
- https://doi.org/10.1038/leu.2011.293
Abstract
D816V KIT mutation of bone marrow (BM) mast cells (MC) is a common feature to systemic mastocytosis (SM) patients. Nevertheless, occurrence of the KIT mutation in BM cell compartments other than MC is associated with progression to more aggressive forms of the disease and poor outcome in indolent SM (ISM). Here, we assessed the potential association between the immunophenotype of MC and multilineage KIT mutation in the BM of SM patients through the investigation of the flow cytometric protein expression profile (PEP) of bone marrow mast cells (BMMC) from 70 control individuals and 206 SM patients, classified according to the WHO (World Health Organization), and the degree of involvement of BM hematopoiesis by the D816V KIT mutation; additionally, we developed a score-based class prediction algorithm for the detection of SM cases with multilineage mutation. Our results show that aberrant expression of CD25 with a FceRI(lo), FSClo, SSClo and CD45(lo) immature phenotype of BMMC, in the absence of coexisting normal MC in the BM, was associated with multilineage involvement by the D816V KIT mutation, regardless of the diagnostic subtype of the disease (for example, indolent vs aggressive SM), which supports the utility of the immunophenotype of BMMC as a surrogate marker to screen for multilineage KIT mutation in ISM.Peer RevieweKeywords
This publication has 20 references indexed in Scilit:
- Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptomsJournal of Allergy and Clinical Immunology, 2010
- Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypesJournal of Allergy and Clinical Immunology, 2010
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsBlood, 2009
- Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levelsJournal of Allergy and Clinical Immunology, 2009
- The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursorsLeukemia, 2008
- Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxisBlood, 2007
- KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patientsBlood, 2006
- Detection of differentiation‐ and activation‐linked cell surface antigens on cultured mast cell progenitorsAllergy, 2005
- A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinibBlood, 2004
- Well-differentiated systemic mastocytosis*1A new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutationsJournal of Allergy and Clinical Immunology, 2004